| The power of genetic diversity in genome-wide association studies of lipids SE Graham, SL Clarke, KHH Wu, S Kanoni, GJM Zajac, S Ramdas, ... Nature 600 (7890), 675-679, 2021 | 634 | 2021 |
| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update LB Ramsey, SG Johnson, KE Caudle, CE Haidar, D Voora, RA Wilke, ... Clinical Pharmacology & Therapeutics 96 (4), 423-428, 2014 | 478 | 2014 |
| The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy RA Wilke, LB Ramsey, SG Johnson, WD Maxwell, HL McLeod, D Voora, ... Clinical Pharmacology & Therapeutics 92 (1), 112-117, 2012 | 377 | 2012 |
| Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins I Postmus, S Trompet, HA Deshmukh, MR Barnes, X Li, HR Warren, ... Nature communications 5 (1), 5068, 2014 | 291 | 2014 |
| A statin-dependent QTL for GATM expression is associated with statin-induced myopathy LM Mangravite, BE Engelhardt, MW Medina, JD Smith, CD Brown, ... Nature 502 (7471), 377-380, 2013 | 236 | 2013 |
| Learning from longitudinal data in electronic health record and genetic data to improve cardiovascular event prediction J Zhao, QP Feng, P Wu, RA Lupu, RA Wilke, QS Wells, JC Denny, ... Scientific reports 9 (1), 717, 2019 | 233 | 2019 |
| Phenotype risk scores identify patients with unrecognized Mendelian disease patterns L Bastarache, JJ Hughey, S Hebbring, J Marlo, W Zhao, WT Ho, ... Science 359 (6381), 1233-1239, 2018 | 217 | 2018 |
| A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease CA Emdin, ME Haas, AV Khera, K Aragam, M Chaffin, D Klarin, G Hindy, ... PLoS genetics 16 (4), e1008629, 2020 | 160 | 2020 |
| Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects D Gill, MK Georgakis, F Koskeridis, L Jiang, Q Feng, WQ Wei, ... Circulation 140 (4), 270-279, 2019 | 146 | 2019 |
| Predictive utility of polygenic risk scores for coronary heart disease in three major racial and ethnic groups O Dikilitas, DJ Schaid, ML Kosel, RJ Carroll, CG Chute, JC Denny, ... The American Journal of Human Genetics 106 (5), 707-716, 2020 | 118 | 2020 |
| Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene–environment interaction study CA Emdin, M Haas, V Ajmera, TG Simon, J Homburger, C Neben, L Jiang, ... Gastroenterology 160 (5), 1620-1633. e13, 2021 | 111 | 2021 |
| LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins WQ Wei, X Li, Q Feng, M Kubo, IJ Kullo, PL Peissig, EW Karlson, ... Circulation 138 (17), 1839-1849, 2018 | 100 | 2018 |
| Harmonizing clinical sequencing and interpretation for the eMERGE III network H Zouk, E Venner, NJ Lennon, DM Muzny, D Abrams, S Adunyah, ... The American Journal of Human Genetics 105 (3), 588-605, 2019 | 98 | 2019 |
| Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions QP Feng, RA Wilke, TM Baye Pharmacogenomics 13 (5), 579-594, 2012 | 88 | 2012 |
| Genetic association with overall survival of taxane-treated lung cancer patients-a genome-wide association study in human lymphoblastoid cell lines followed by a clinical … N Niu, DJ Schaid, RP Abo, K Kalari, BL Fridley, Q Feng, G Jenkins, ... BMC cancer 12, 1-13, 2012 | 87 | 2012 |
| Human betaine-homocysteine methyltransferase (BHMT) and BHMT2: common gene sequence variation and functional characterization F Li, Q Feng, C Lee, S Wang, LL Pelleymounter, I Moon, BW Eckloff, ... Molecular genetics and metabolism 94 (3), 326-335, 2008 | 84 | 2008 |
| Returning integrated genomic risk and clinical recommendations: The eMERGE study JE Linder, A Allworth, HT Bland, PJ Caraballo, RL Chisholm, EW Clayton, ... Genetics in Medicine 25 (4), 100006, 2023 | 72 | 2023 |
| Betaine-homocysteine methyltransferase: Human liver genotype–phenotype correlation Q Feng, K Kalari, BL Fridley, G Jenkins, Y Ji, R Abo, S Hebbring, J Zhang, ... Molecular genetics and metabolism 102 (2), 126-133, 2011 | 69 | 2011 |
| Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations NJ Lennon, LC Kottyan, C Kachulis, NS Abul-Husn, J Arias, G Belbin, ... Nature Medicine 30 (2), 480-487, 2024 | 67 | 2024 |
| Clinical Pharmacogenomics Implementation Consortium (CPIC). The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy RA Wilke, LB Ramsey, SG Johnson, WD Maxwell, HL McLeod, D Voora, ... Clin Pharmacol Ther 92 (1), 112-117, 2012 | 62 | 2012 |
Wei-Qi WeiVanderbilt University Medical CenterVerified email at vumc.org
